CCE
0.35
75%
H2G
0.006
-33.3%
PGO
0.17
61.9%
M2R
0.002
-33.3%
IOV
0.535
57.4%
PEN
0.245
-32.9%
CLA
0.006
50%
MNB
0.017
-29.2%
SGA
0.089
48.3%
TRP
0.078
-29.1%
OFX
0.77
46.7%
CCA
0.052
-25.7%
SLB
0.215
43.3%
SLD
0.4
-25.2%
KEY
0.135
42.1%
CAN
0.003
-25%
NVU
0.061
41.9%
IRD
0.009
-25%
AMD
0.007
40%
MOH
0.006
-25%
ION
0.04
37.9%
JGH
0.076
-24%
EV1
0.011
37.5%
ALV
0.017
-22.7%
G50
0.66
37.5%
OLY
0.04
-21.6%
LDX
0.11
37.5%
AZ9
0.015
-21.1%
BNZ
3.26
35.8%
LRM
0.019
-20.8%
ECT
0.135
35%
HRE
0.032
-20%
MYE
0.45
32.4%
IPD
0.004
-20%
CG1
0.088
31.3%
RAP
0.024
-20%
CPN
0.13
30%
FTI
0.49
-18.3%
FMN
0.195
30%
BST
0.32
-17.9%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

August 20, 2024: TSN’s ASX weekly wrap

TSN weekly wrap | Despite the fall in the market last week, the ASX made a slight recovery this week. For the week, the index jumped 193.4 points, or 2.4 per cent, as profits broadly delivered on expectations and bond yields eased #ASX #ASXStocks #investment #australianstockhorse #stockshow #investing #asxweeklywrap #recession

Frontier Energy (ASX:FHE) appoints former Western Australia Premier as Non-Executive Chairman

Frontier Energy (ASX:FHE; OTCQB: FRHYF) has appointed the former Western Australian Premier, Mark McGowan AC, the 30th Premier of Western Australia, as Non-Executive Chairman. McGowan AC will be appointed as Non-Executive Chairman as Frontier transitions from renewable electricity developer to major renewable energy producer McGowan brings a deep understanding of WA’s electricity landscape and key […]

Globe Metals & Mining (ASX:GBE): CDA signed with communities surrounding the Kanyika Project

Globe Metals & Mining (ASX: GBE) has signed the Community Development Agreement (CDA) with the representatives of the qualified communities surrounding the Company’s Kanyika Niobium Project. 🖊️Signed a Community Development Agreement (CDA) with representatives of communities surrounding the Kanyika Project 🤝The signing ceremony was attended by various senior dignitaries. 📍The CDA sets out the guidelines […]

What’s Hot – LRS, ODY, ARV, LSA, OSL, PDI & LTP

What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – LRS, ODY, ARV, LSA, OSL, PDI & LTP What’s Not – RGT What’s Hot LRS – Latin Resources Limited today closed up 54% to finish at 18.5c on $39m stock traded. The reason they were up […]

What’s Hot – LVH, AQC, APX, WTM, PCL, ION, NOX & LRS

What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – LVH, AQC, APX, WTM, PCL, ION, NOX & LRS What’s Not – AUK What’s Hot LVH – LiveHire Limited today closed up 88% to finish at 4.5c on $3.8m stock traded. The reason they were up […]

Noxopharm (ASX:NOX) announces significant CRO-67 results in complex pancreatic cancer studies

Noxopharm (ASX:NOX) has announced encouraging new data regarding its CRO-67 preclinical drug for pancreatic cancer. CRO-67 targets pancreatic cancer in a different and innovative way. The latter cancer is especially difficult to treat because tumours are surrounded by a dense barrier of cells that protects them from anti-cancer drugs, as well as from the body’s […]

What’s Hot – BPH, AGC, LTP, TPW, PRA, QML, 3DA, RAU, WTM & TYP

What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – BPH, AGC, LTP, TPW, PRA, QML, 3DA, RAU, WTM & TYP What’s Not – SEK What’s Hot BPH – BPH Energy Limited today closed up 39% to finish at 2.6c on $440k stock traded. There was […]

QMines (ASX:QML): Commences drilling at Develin Creek

QMines (ASX:QML) has revealed that the drilling program at the Company’s Develin Creek project is now underway. 🚜 Drill rig arrives onsite with drilling expected to commence imminently 🪨 Phase one program designed to bring the high-grade Scorpion open-pit resource into the Mt Chalmers mine plan ⛏️ Drilling program planned to infill the existing resource […]

PYC Therapeutics (ASX:PYC): Reports vision improvement in multiple RP11 patients

PYC Therapeutics (ASX:PYC) has developed the only clinical-stage investigational drug candidate designed specifically for patients with the blinding eye disease Retinitis Pigmentosa type 11 (RP11). 👁️ PYC recently reported an improvement in vision in 2 patients with RP11 📣 PYC will announce further results from the ongoing multiple dose studies of VP-001 in Q4 2024 […]